Patrick Frankham
Director
Pharmaceuticals Science
Pivot Pharmaceuticals
Canada
Biography
Dr. Patrick Frankham founded several healthcare startup enterprises including healthcare information technology, services and pharmaceuticals companies. Dr. Frankham has over 20 years of experience in the biopharmaceutical and services industries across several therapeutic areas. His professional experience includes public and private companies as well as multinational corporations. Notable prior organizations where he held increasing leadership roles in Preclinical, Regulatory, Medical and Business Development include Phoenix International Life Sciences (MDS Pharma Services), AeternaZentaris, BioAxone Biosciences, ICON Clinical Research & Boehringer Ingelheim GmbH. While at Boehringer Ingelheim, he developed novel business models to optimize therapeutics by combining mobile technology and therapies. He is currently Vice President International, Physicians Interactive. Dr Frankham obtained his PhD in Molecular Endocrinology, Unversité Laval, Québec, Canada and his MBA in Management & Finance, University of Liverpool, UK. Dr. Patrick Frankham founded several healthcare startup enterprises including healthcare information technology, services and pharmaceuticals companies. Dr. Frankham has over 20 years of experience in the biopharmaceutical and services industries across several therapeutic areas. His professional experience includes public and private companies as well as multinational corporations. Notable prior organizations where he held increasing leadership roles in Preclinical, Regulatory, Medical and Business Development include Phoenix International Life Sciences (MDS Pharma Services), AeternaZentaris, BioAxone Biosciences, ICON Clinical Research & Boehringer Ingelheim GmbH. While at Boehringer Ingelheim, he developed novel business models to optimize therapeutics by combining mobile technology and therapies. He is currently Vice President International, Physicians Interactive. Dr Frankham obtained his PhD in Molecular Endocrinology, Unversité Laval, Québec, Canada and his MBA in Management & Finance, University of Liverpool, UK.
Research Interest
Pharmaceuticals Science and Biotechnology
